2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | 900-1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 1.626.025 | 310.938 | 1 | ||
2012 | 0 | 11.969.198 | 1.271.156 | 2 |
Total number of partners: 34
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 34
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-04-01 | Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus | Solnatide | participant | 1.626.025 | 6 |
2012-11-01 | Glioma Actively Personalized Vaccine Consortium | GAPVAC | participant | 5.970.436 | 13 |
2012-03-01 | European Consortium for the Early Treatment of Diabetic Retinopathy | EUROCONDOR | participant | 5.998.762 | 18 |